Skip to Content

APO LET 2.5 (Letrozole 2.5 mg)

Pill with imprint APO LET 2.5 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Apotex Corp..

Letrozole is used in the treatment of female infertility; breast cancer, metastatic; breast cancer; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO LET 2.5

Letrozole

Imprint:
APO LET 2.5
Strength:
2.5 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Aromatase inhibitors
Hormones/antineoplastics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Apotex Corp.
Inactive Ingredients:
hydroxypropyl cellulose
hypromelloses
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol 8000
sodium starch glycolate type A potato
titanium dioxide
ferric oxide yellow
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
68084-0803 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide